Earth Day marks a moment to reflect on the planet's health and our collective efforts to nurture it. To celebrate Earth Day, this article will examine the strides the pharmaceutical and biotechnology industry has made towards fostering sustainable and green practices alongside the challenges.

Recombinant and chemical peptide synthesis methods both have use cases in modern peptide production. Today the industry is looking to sustainable approaches to both.

Sustainable peptide synthesis refers to the development and implementation of methods that minimize the environmental impact of peptide manufacturing while maintaining high efficiency and yield.

Mechanochemical synthesis could unlock new pathways for obtaining peptides in a sustainable and ecologically friendly way.

The preclinical peptide could unlock much needed treatment options for patients with triple-negative breast cancer.

Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.

The Sustainable Healthcare Coalition (SHC) emphasises the importance of collaboration with industry to address climate change in healthcare.

A program to reduce the waste of medicines and waste from medicines, centred around six pillars for sustainable pharma.

Key opinion leaders discuss techniques for peptide characterisation and the challenges posed by increasing regulatory requirements.

Novo Nordisk has implemented recombinant peptide production techniques with chemical and enzymatic transformations to reduce its carbon footprint in insulin production, as explained by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk.

Are plant-derived peptides set to replace animal proteins as the go-to supplement for muscle conditioning?

The peptide market is continually developing, but how are manufacturers responding to its new requirements and altering the landscape of peptide manufacturing?

Competition between cosmetic treatments begins.

Vyepti is the first intravenous medication approved for migraine treatment.

Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.

In this Commentary article, we explore how innovative technologies like expression tags could help to overcome challenges associated with recombinant peptide production. The potential for recombinant production to slash manufacturing costs has made it a focal area of research for companies such as Boehringer Ingelheim.

UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our January Discussion Group addressing ‘Peptides Green Chemistry Strategies and Methods’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.

In this Insight Article, we explore the future possibilities, challenges, and solutions in peptide purification and the delivery of precision medicine for immunotherapy.

What are the key market trends and challenges facing the Peptides therapeutic industry today? We sat down with an advisory group of leading pharmaceutical and academic experts to discuss our latest Peptides Congress and the interesting insights it disclosed.

Strides made in a landmark phase IIb oral insulin clinical trial.